TY - JOUR
T1 - GABA type a receptor activation in the allosteric coagonist model framework
T2 - Relationship between EC50 and basal activity
AU - Akk, Gustav
AU - Shin, Daniel J.
AU - Germann, Allison L.
AU - Steinbach, Joe Henry
N1 - Publisher Copyright:
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics.
PY - 2018/2
Y1 - 2018/2
N2 - The concerted transition model for multimeric proteins is a simple formulation for analyzing the behavior of transmitter-gated ion channels.Weused the model to examine the relationship between the EC50 for activation of the GABA type A (GABAA) receptor by the transmitter GABA and basal activity employing concatemeric ternary GABAA receptors expressed in Xenopus oocytes. Basal activity, reflecting the receptor function in the absence of the transmitter, can be changed either by mutation to increase constitutive activity or by the addition of a second agonist (acting at a different site) to increase background activity. The model predicts that either mechanism for producing a change in basal activity will result in identical effects on the EC50. We examined receptor activation by GABA while changing the level of basal activity with the allosterically acting anesthetics propofol, pentobarbital, or alfaxalone. We found that the relationship between EC50 and basal activity was well described by the concerted transition model. Changes in the basal activity by gain-of-function mutations also resulted in predictable changes in the EC50. Finally, we altered the number of GABA-binding sites by a mutation and again found that the relationship could be well described by the model. Overall, the results support the idea that interactions between the transmitter GABA and the allosteric agonists propofol, pentobarbital, or alfaxalone can be understood as reflecting additive and independent free energy changes, without assuming any specific interactions.
AB - The concerted transition model for multimeric proteins is a simple formulation for analyzing the behavior of transmitter-gated ion channels.Weused the model to examine the relationship between the EC50 for activation of the GABA type A (GABAA) receptor by the transmitter GABA and basal activity employing concatemeric ternary GABAA receptors expressed in Xenopus oocytes. Basal activity, reflecting the receptor function in the absence of the transmitter, can be changed either by mutation to increase constitutive activity or by the addition of a second agonist (acting at a different site) to increase background activity. The model predicts that either mechanism for producing a change in basal activity will result in identical effects on the EC50. We examined receptor activation by GABA while changing the level of basal activity with the allosterically acting anesthetics propofol, pentobarbital, or alfaxalone. We found that the relationship between EC50 and basal activity was well described by the concerted transition model. Changes in the basal activity by gain-of-function mutations also resulted in predictable changes in the EC50. Finally, we altered the number of GABA-binding sites by a mutation and again found that the relationship could be well described by the model. Overall, the results support the idea that interactions between the transmitter GABA and the allosteric agonists propofol, pentobarbital, or alfaxalone can be understood as reflecting additive and independent free energy changes, without assuming any specific interactions.
UR - http://www.scopus.com/inward/record.url?scp=85041213042&partnerID=8YFLogxK
U2 - 10.1124/mol.117.110569
DO - 10.1124/mol.117.110569
M3 - Article
C2 - 29150461
AN - SCOPUS:85041213042
SN - 0026-895X
VL - 93
SP - 90
EP - 100
JO - Molecular pharmacology
JF - Molecular pharmacology
IS - 2
ER -